Home › Funds › Two Sigma Investments › BBIO
Two Sigma Investments position in BBIO
BRIDGEBIO PHARMA INC · Health Care
Latest position (Q2 2026)4.75M sh
Reported value held$353.43M
Portfolio Weight0.27%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 46.72K | $2.19M | New |
| Q4 2021 | 606.19K | $10.11M | Add |
| Q1 2022 | 509.55K | $5.17M | Reduce |
| Q2 2022 | 151.26K | $1.37M | Reduce |
| Q3 2022 | 871.21K | $8.66M | Add |
| Q4 2022 | 651.21K | $4.96M | Reduce |
| Q1 2023 | 779.54K | $12.92M | Add |
| Q2 2023 | 740.39K | $12.73M | Reduce |
| Q3 2023 | 1.28M | $33.68M | Add |
| Q4 2023 | 966.80K | $39.03M | Reduce |
| Q1 2024 | 744.60K | $23.02M | Reduce |
| Q2 2024 | 565.45K | $14.32M | Reduce |
| Q3 2024 | 381.24K | $9.71M | Reduce |
| Q4 2024 | 238.54K | $6.55M | Reduce |
| Q1 2025 | 843.32K | $29.15M | Add |
| Q2 2025 | 2.34M | $101.00M | Add |
| Q3 2025 | 2.33M | $120.97M | Hold |
| Q4 2025 | 1.95M | $148.93M | Reduce |
| Q1 2026 | 3.12M | $231.74M | Add |
| Q2 2026 | 4.75M | $353.43M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BBIO
- Vanguard Group 16.86M sh · $1.29B · Q4 2025
- Janus Henderson Group 13.18M sh · $978.61M · Q1 2026
- Farallon Capital Management 10.74M sh · $800.14M · Q2 2026
- Viking Global Investors 9.95M sh · $741.02M · Q2 2026
- D. E. Shaw & Co 3.66M sh · $272.89M · Q2 2026
- Geode Capital Management 3.42M sh · $254.67M · Q2 2026
- Manulife Financial 1.96M sh · $145.66M · Q2 2026
- Charles Schwab Investment Management 1.71M sh · $127.32M · Q2 2026
- Norges Bank Investment Management 1.69M sh · $126.15M · Q2 2026
- Morgan Stanley 1.69M sh · $126.14M · Q2 2026
- Point72 Asset Management 1.53M sh · $114.16M · Q2 2026